Shankar Deepak Panmand

Title: **Shankar Deepak Panmand: Innovator in Antiemetic Pharmaceutical Processes**

Introduction

Shankar Deepak Panmand, based in Maharashtra, India, is a notable inventor in the field of pharmaceuticals, particularly recognized for his contributions to the development of antiemetic agents. His innovative approach to drug formulation has significantly advanced the efficiency of producing essential medications.

Latest Patents

Shankar holds a patent for a groundbreaking process titled "One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O". This innovative one-pot industrial process aims to synthesize the compound 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one from its precursor through a series of reactions involving HNRRsalt and paraformaldehyde, in a solvent system of acetic acid and hydrocarbon solvent. The process enhances efficiency by allowing the conversion to ondansetron directly without the need for isolation of intermediate compounds.

Career Highlights

Shankar is currently employed at Ipca Laboratories Limited, where he engages in innovative research and development in pharmaceutical processes. His expertise and dedication have helped improve existing methodologies and opened new avenues in drug preparation that contribute to the healthcare sector.

Collaborations

Throughout his career, Shankar has collaborated with talented professionals, including his coworkers Ashok Kumar and Dharmendra Singh. Their collective efforts exemplify teamwork in advancing pharmaceutical sciences and innovation.

Conclusion

Shankar Deepak Panmand stands out as a dedicated inventor whose work in the pharmaceutical industry illustrates the importance of innovation in drug development. His patented processes not only enhance the production of crucial antiemetic agents but also underline the significant role of inventors in advancing medical science and improving patient care.